Consensus TransCode Therapeutics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 10:05:00 2024-05-10 am EDT			5-day change	1st Jan Change
1.47 ^USD	+10.53%		+86.57%	-76.79%

Apr. 22	Certain Warrants of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 22-APR-2024.	CI
Apr. 22	Certain Stock Options of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 22-APR-2024.	CI

d2791bbba58a.y2VySmmD1jepY_1Yi585WRFusMBQGHjdWcs3oAUeREs.glEUBwLS5mbmK58ow6hJHyJd3vAHeS-1LJMD6WJrNgePXR19I67gdtNXtA~f927e3d9af87467934aafe046b6b4081

Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	23-09-20	MT
US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	23-09-20	MT
Traders Stay Cautious Ahead of Fed Rate Decision, Weighing on US Equity Futures	23-02-01	MT
HC Wainwright Adjusts Price Target on TransCode Therapeutics to $6 From $10, Maintains Buy Rating	22-11-15	MT
HC Wainwright Starts TransCode Therapeutics at Buy With $10 Price Target	22-06-07	MT

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.33 USD

Average target price

3 USD

Spread / Average Target

+125.56%

High Price Target

3 USD

Spread / Highest target

+125.56%

Low Price Target

3 USD

Spread / Lowest Target

+125.56%

HC Wainwright